Protecting New Life: The First Line of Diagnostic Defense.
TORCH screening informs profound decisions where there is no margin for error. The absolute confidence required for these critical tests is engineered at the source by our NomoFlow™ platform, providing a verifiable foundation for every result.
Our Comprehensive Prenatal Screening Portfolio
Reliable tools to help safeguard maternal and fetal health.
TORCH IgG/IgM Antibody (TOXO, Rubella, CMV, HSV-I, HSV-II) Combo Test
A core component of fertility and prenatal care, providing a comprehensive assessment of infection risk.
Cytomegalovirus (CMV) IgG/IgM Antibody Test
To differentiate between acute and past CMV infections.
Toxoplasma gondii IgG/IgM Antibody Test
To differentiate between acute and past Toxoplasma infections.
Rubella IgG/IgM Antibody Rapid Test
To differentiate infections and assess vaccine efficacy.
Herpes Simplex Virus 1 (HSV-1) IgG/IgM Test
To differentiate between acute and past HSV-1 infections.
Herpes Simplex Virus 2 (HSV-2) IgG/IgM Test
To differentiate between acute and past HSV-2 infections.
The Engineering Behind Diagnostic Confidence
Accurately detecting multiple IgG and IgM antibody pairs on a single device is a formidable technical challenge. The slightest inconsistency in antigen coating can lead to ambiguous results, causing unnecessary patient anxiety.
The NomoFlow™ platform's precision deposition process solves this. It ensures that each of the ten or more reagent lines in a TORCH combo panel is applied with microscopic uniformity, guaranteeing independent performance and eliminating cross-reactivity. This is how we transform a complex assay into a clear, reliable result.